The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Treatment strategies to prevent stroke: focus on optimal lipid and blood pressure control.

TitleTreatment strategies to prevent stroke: focus on optimal lipid and blood pressure control.
Publication TypeJournal Article
Year of Publication2009
AuthorsPapademetriou, V., & Doumas M.
JournalExpert Opin Pharmacother
Volume10
Issue6
Pagination955-66
Date Published2009 Apr
ISSN1744-7666
KeywordsAnimals, Antihypertensive Agents, Blood Pressure, Controlled Clinical Trials as Topic, Disease Management, Humans, Hypertension, Hypolipidemic Agents, Lipids, Risk Factors, Stroke, Treatment Outcome
Abstract

Stroke is a major cause of death and disability, and its prevalence is expected to rise as the population continues to age. Most strokes can be prevented through risk-factor modification and application of effective preventive therapies. Although treatment of dyslipidemia, control of diabetes mellitus, smoking cessation and treatment of atrial fibrillation contribute substantially to stroke prevention, hypertension control remains the single most important intervention. Control of hypertension with diuretics, beta-blockers, inhibitors of the renin-angiotensin system and calcium channel blockers can reduce the risk of first and recurrent stroke. Although blood pressure normalization seems to be the main mechanism for stroke prevention, specific drug effects may also contribute. Findings from recent clinical studies and meta-analyses suggest that calcium channel blockers may have an advantage in stroke prevention. Mechanisms for this greater efficacy may include more effective blood pressure reduction and possibly antiatherosclerotic actions observed with dihydropyridines. The objective of this paper is to discuss effective interventions for optimal stroke prevention, with an emphasis on effective antihypertensive and lipid lowering therapy.

DOI10.1517/14656560902877705
Alternate JournalExpert Opin Pharmacother
PubMed ID19364247

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.